NEW YORK (GenomeWeb News) – More than half of the companies operating in the omics tools and molecular diagnostics space saw their stock prices drop in April, resulting in a sluggish GenomeWeb Daily News Index for the month.

Of the 29 firms in the GWDN Index, 16 declined during the past month, and overall the index inched up less than 1 percent. It trailed the Dow Jones Industrial Average and the Nasdaq, which grew a little less than 2 percent each, as well as the Nasdaq Biotech Index, which gained almost 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.